Image via GN — ASX:RMD Resmed
Last updated
ResMed: Ma Activity
ResMed facing ventilator issues that could cloud FY27 performance, despite otherwise strong earnings growth outlook
Source: GN — ASX:RMD Resmed
The leadership read
Consolidation shifts the leadership question from growth to integration. For ResMed in the sector, the demand moves toward transformation and integration leaders who can merge teams, systems and cultures without losing momentum. Across Oceania, watch whether the integration is properly resourced; deals are won or lost the year after they close.
Market context: MitchelLake's Talent Market Index sits at 104.6 (Hot), down 1.9 on the prior month; Oceania hiring signal is running steady (+1.1pts).
ResMed: 5 signals in the last 90 days; 0.2% of MitchelLake's EMEA signal flow; 5 tracked across 61 days.
Also at ResMed →
More signals across Oceania
Ma Activity · Oceania
Mirvac →Mirvac is in advanced negotiations to acquire half-stakes in two premium-grade east coast CBD office towers: 5 Martin Place in Sydney and 171 Collins Street in Melbourne. Combined deal value estimated at over $630 million. Assets to be held by the Mirvac Wholesale Office Fund. Vendor is Cbus Property.
Ma Activity · Oceania
Gigacomm →Gigacomm (backed by Macquarie Capital and Palisade Impact) acquired DGTek's retail brand Pineapple Net, gaining a foothold in Victoria's internet provider market.
Ma Activity · Oceania
Scalare Partners →Scalare Partners completed acquisition of Fishburners; cash balance increased to $1.82 million post-transaction
Ma Activity · Oceania
Worldline →Worldline completed divestment of ANZ Worldline Payment Solutions joint venture in Australia to ANZ. This represents the finalization of a JV exit transaction.
Ma Activity · Oceania
Insignia Financial →Insignia Financial divests its funds management business Antares Capital Partners and stake in Fairview Equity Partners (combined $33B AUM) to Janus Henderson
Ma Activity · Oceania
ClearView Wealth Limited →ClearView Wealth acquisition by Zurich Financial Services Australia is now effective. Scheme of arrangement approved by NSW Supreme Court; ASX trading suspension effective close of 31 July 2026; scheme consideration of A$0.60 per share to be paid 20 August 2026.
Intelligence powered by Autonodal ↗